Samuel Levi is a Senior Principal Scientist at Pfizer, a role they began in 2024 after previously serving as Principal Scientist from 2020 to 2024. They completed a Ph.D. in Chemical Biology at Harvard University in 2018 and hold a B.A./M.S. in Organic Chemistry from the University of Pennsylvania. Samuel gained research experience as a graduate student at Harvard and as a research assistant at both the University of Minnesota and the University of Pennsylvania. Additionally, they interned at Merck, focusing on the synthesis of A2A antagonists related to Parkinson’s Disease in 2012.
This person is not in any teams
This person is not in any offices